Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2025 ∙ Patel, V. Korsun, M. Cervia, J. S.

EXPRESS: Protective Effects of Booster Dose of SARS-COV-2 Vaccination Against Post-Acute COVID-19 Syndrome: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Mirza, A. A. Almalki, A. H. Noori, F. A. Neazy, S. A. Dahm, V. Bajin, M. D. Lin, V. Y.

Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Chaudhry, T. Tum, P. Morrow, F. Hargreaves, S. Kielmann, K. Kunst, H. Griffiths, C. Campbell, N. J. C. Zenner, D.

Facilitators to strengthening vaccine uptake post-pandemic amongst underserved populations considering social norms and health beliefs: a global systematic review

  • Adults
  • Older adults
  • Parents/caregivers
  • COVID-19
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Rudolph, A. E. Al Akoury, N. Bogdanenko, N. Markus, K. Whittle, I. Wright, O. Haridy, H. Spinardi, J. R. McLaughlin, J. M. Kyaw, M. H.

Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Moreira da Cunha, N. Tzirita, S. Gobbo, E. Herzig van Wees, S.

Factors influencing adolescents' decision-making about COVID-19 vaccination: a systematic review with qualitative synthesis

  • Adolescents
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Xu, Q. Zhao, T. Cai, X. Wang, M. Ao, L. Wei, T. Yang, H. Zhang, S. Zhang, X. Jin, S. Wang, X. Feng, X. Zhao, J. Wu, Y. Yang, J. Cui, F.

Global Hesitancy of COVID-19 Vaccine Among Vulnerable Population From 2020 to 2023: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Zhao, T. Xu, Q. Cai, X. Wang, M. Ao, L. Wei, T. Yang, H. Zhang, S. Zhang, X. Jin, S. Wang, X. Feng, X. Zhao, J. Wu, Y. Yang, J. Cui, F.

Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Magalhaes, B. A. P. Medeiros Minasi, J. Lobato, R. C. Lemos, L. C. de Britto, L. S. Barros, R. M. de Martinez, A. M. B. da Hora, V. P.

Globally approved vaccines for COVID-19: a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Zhang, C. Zhang, Y. Q. Liu, R. B. Ma, Y. T. Zhao, L. K. Yin, F. Q. Tu, J. Yao, Y. Y.

Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Hoang, T. N. A. Byrne, A. Quach, H. L. Bannister-Tyrrell, M. Vogt, F.

How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...